Cantor says Bristol joins ‘radiopharmaceuticals race’ with RayzeBio deal
PremiumThe FlyCantor says Bristol joins ‘radiopharmaceuticals race’ with RayzeBio deal
9M ago
Pnt Biopharma Global put volume heavy and directionally bearish
Premium
The Fly
Pnt Biopharma Global put volume heavy and directionally bearish
9M ago
Salesforce upgraded, Chipotle downgraded: Wall Street’s top analyst calls
Premium
The Fly
Salesforce upgraded, Chipotle downgraded: Wall Street’s top analyst calls
9M ago
Lantheus, Point Biopharma report SPLASH trial met primary endpoint
PremiumThe FlyLantheus, Point Biopharma report SPLASH trial met primary endpoint
9M ago
Lantheus, Point Biopharma report topline results from Phase 3 SPLASH trial
Premium
The Fly
Lantheus, Point Biopharma report topline results from Phase 3 SPLASH trial
9M ago
Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer
Premium
Press Releases
Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer
9M ago
Eli Lilly extends tender offer to acquire Point Biopharma for $12.50 per share
PremiumThe FlyEli Lilly extends tender offer to acquire Point Biopharma for $12.50 per share
10M ago
Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 1, 2023
Premium
Press Releases
Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 1, 2023
10M ago
Eli Lilly receives NRC consent regarding proposed Point Biopharma acquisition
Premium
The Fly
Eli Lilly receives NRC consent regarding proposed Point Biopharma acquisition
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100